FDA investigates cholesterol drug (Moldova.org)
Tue, 26 Aug 2008 10:00:14 +0500
FDA investigates cholesterol drug (Moldova.org)
Filled in CholesterolThe U.S. Food and Drug Administration said it is investigating a report of a possible increased cancer risk for patients who take the drug Vytorin.Vytorin is a combination of simvastatin, marketed as Zocor, and ezetimibe, marketed as Zetia. It was approved as a combination drug in 2004 to reduce LDL-choloesterol levels.Preliminary results of a clinical trial to see if lowering LDL-cholesterol ...
FDA investigates cholesterol drug (UPI)
WASHINGTON, Aug. 23 (UPI) -- The U.S. Food and Drug Administration said it is investigating a report of a possible increased cancer risk for patients who take the drug Vytorin.
Cholesterol Drug's Cancer Risk Probed (The Tampa Tribune)
Federal drug safety regulators said Thursday they are investigating whether the cholesterol-lowering drug Vytorin can increase patients' risk of developing cancer. more more more
Tags: Cholesterol